A Roundabout Route To Rejection: The Contribution of Cross‐Primed CD8 T Cells

J. Bradley
DOI: https://doi.org/10.1111/j.1600-6143.2004.00452.x
IF: 9.369
2004-05-01
American Journal of Transplantation
Abstract:Cytotoxic CD8 T lymphocytes (CTLs) play an essential role in the defence against infection by intracellular pathogens, particularly viruses. They are able, with great precision, to kill individual virally infected cells in tissues, thereby limiting viral replication while causing minimal damage to healthy tissues. The attributes that CD8 CTLs have evolved to eliminate cells infected with pathogens also make them potent effector cells during allograft rejection and there is abundant evidence that CD8 T cells may mediate rejection of class I MHC-incompatible allografts (1). In this issue of the American Journal of Transplantation, He et al. report that CD8 T cells are also able to reject murine skin allografts even when the grafts are completely devoid of class I MHC (2). This novel observation has potentially important implications for understanding how CD8 T cells may mediate rejection. To appreciate these it is helpful to first recap briefly the relevant aspects of CD8 T-cell immunobiology.
What problem does this paper attempt to address?